ASSET SEARCH & EVALUATION
ASSET SEARCH & EVALUATION
Situation: A US biotech company experienced a series of unexpected setbacks in their pipeline. To mitigate this, they desired to in-license several assets to fill the gaps
Approach: SCITARIS deployed our systematic asset search methodology which utilizes priority algorithms to filter and priortize 18k+ biopharma drugs in development world-wide, with the top-ranked candidates analyzed first at a high-level and then by comprehensive deep-dive review
Outcome: The firm presented severals candidates to their board and the decision was taken to in-license
